首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Pediatric clinical features of Mycoplasma pneumoniae infection are associated with bacterial P1 genotype
【2h】

Pediatric clinical features of Mycoplasma pneumoniae infection are associated with bacterial P1 genotype

机译:肺炎支原体感染的儿科临床特征与细菌P1基因型相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study evaluated the association between different Mycoplasma pneumoniae (M. pneumonia) genotypes and clinical features of pediatric patients. Subjects were children diagnosed with community-acquired pneumonia at the Children's Hospital of Soochow University (Suzhou, China) from January 2012 to December 2013. Clinical and laboratory tests were conducted and clinical samples positive for M. pneumoniae were genotyped by nested-multiplex polymerase chain reaction. Three type I strains and three type II strains were also randomly selected for sequencing. A total of 335 clinical samples positive for M. pneumoniae were obtained. The average age of M. pneumonia-infected pediatric patients was 4.8±3.3 (years). Genotyping results identified 304 positive samples as group I strains and 30 samples as group II strains, in which 1 sample was type II variant 2a. It was also observed that point mutations were more likely to occur in type I strains compared with type II strains. Although clinical pulmonary infection scores between patients with type I and type II strains did not significantly differ, patients with type I strains had a higher risk of developing severe M. pneumoniae pneumonia (SMPP) and extrapulmonary complications, and had significantly higher percentages of peripheral blood neutrophils than patients with type II strains (P<0.05). Collectively, these data indicate that the predominant strains of M. pneumoniae in Suzhou between 2012 and 2013 were type I, and that pediatric pneumonia patients with type I strains of M. pneumoniae were more likely to progress to SMPP.
机译:本研究评估了不同的肺炎支原体(M.pneumonia)基因型与儿科患者临床特征之间的关联。受试者为2012年1月至2013年12月在苏州大学儿童医院(中国苏州市)诊断为社区获得性肺炎的儿童。进行了临床和实验室测试,并通过巢式多重聚合酶链法对肺炎支原体呈阳性的临床样本进行了基因分型。反应。还随机选择了三种I型菌株和三种II型菌株进行测序。总共获得了335例肺炎支原体阳性的临床样本。感染肺炎支原体的小儿患者的平均年龄为4.8±3.3(岁)。基因分型结果将304个阳性样品鉴定为I组菌株,将30个样品鉴定为II组菌株,其中1个样品为II型变体2a。还观察到,与II型菌株相比,I型菌株更可能发生点突变。尽管I型和II型毒株之间的临床肺部感染评分没有显着差异,但I型毒株的患者发生严重肺炎支原体肺炎(SMPP)和肺外并发症的风险较高,并且外周血百分比显着较高中性粒细胞比II型菌株患者(P <0.05)。总体而言,这些数据表明,2012年至2013年间苏州市的肺炎支原体主要菌株为I型,患有肺炎支原体I型菌株的小儿肺炎患者更有可能发展为SMPP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号